Evotec SE (EVO) Shares Outstanding (Weighted Average) (2019 - 2026)

Evotec SE's (EVO) quarterly Shares Outstanding (Weighted Average) came in at $208.2 million in Q1 2026, up 11.37% year-on-year from $187.0 million in Q1 2025, and up 0.63% quarter-over-quarter from $206.9 million in Q4 2025.

Evotec SE (EVO) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends

Evotec SE has disclosed Shares Outstanding (Weighted Average) across 8 years of filings, most recently posting $208.2 million for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $208.2 million, up 11.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $208.2 million (up 11.37% YoY), and the FY2025 annual result was $206.9 million, up 9.07% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $208.2 million for Q1 2026 at Evotec SE, up from $206.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $208.2 million in Q1 2026 to a low of $178.2 million in Q3 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $192.6 million (2023), against an average of $194.1 million.
  • Peak annual rise in Shares Outstanding (Weighted Average) reached 10071788.09% in 2022, while the deepest fall reached 5.31% in 2022.
  • Evotec SE's Shares Outstanding (Weighted Average) stood at $180.3 million in 2022, then grew by 5.6% to $190.4 million in 2023, then slipped by 0.33% to $189.7 million in 2024, then advanced by 9.07% to $206.9 million in 2025, then grew by 0.63% to $208.2 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $208.2 million (Q1 2026), $206.9 million (Q4 2025), and $207.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Evotec SE 570.60 Mn 570.08 Mn - 208.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 208.25 Mn
Dec 31, 2025 206.94 Mn
Sep 30, 2025 207.71 Mn
Jun 30, 2025 201.23 Mn
Mar 31, 2025 186.99 Mn
Dec 31, 2024 189.73 Mn
Sep 30, 2024 194.77 Mn
Dec 31, 2023 190.35 Mn
Sep 30, 2023 192.61 Mn
Jun 30, 2023 192.67 Mn
Dec 31, 2022 180.25 Mn
Sep 30, 2022 178.16 Mn
Jun 30, 2022 188.55 Mn
Mar 31, 2022 198.60 Mn
Dec 31, 2021 190.36 Mn
Sep 30, 2021 1,768.93
Jun 30, 2021 83,094.73
Mar 31, 2021 197.93 Mn
Dec 31, 2020 183.32 Mn
Sep 30, 2020 46.72